FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1022 | 71283-1022-1 | Fentanyl Citrate | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0543 | 71283-0543-2 | Alprostadil | 80 ug/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0549 | 71283-0549-2 | Alprostadil; Papaverine Hydrochloride; Atropine Sulfate; Phentolamine Mesylate | 40 ug/1 mL; 25 mg/1 mL; .01 mg/1 mL; .5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0546 | 71283-0546-2 | Alprostadil; Papaverine Hydrochloride; Phentolamine Mesylate | 40 ug/1 mL; 30 mg/1 mL; 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Imprimis NJOF, LLC(080431967)" | Hyaluronidase | 175 1/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ketamine Hydrochloride | 25 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Midazolam; Ketamine Hydrochloride; Ondansetron Hydrochloride | 3 mg; 25 mg; 2 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Triamcinolone Acetonide | 1 mg/1 mL; 15 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 2.5 mg/1 mL; 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Povidone | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Bromfenac; Gatifloxacin | 1 mg/1 mL; .8 mg/1 mL; 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Bromfenac; Gatifloxacin | 1 mg/1 mL; .8 mg/1 mL; 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Gatifloxacin | 1 mg/1 mL; .5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; .5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride; Nepafenac | 1 mg/1 mL; .5 mg/1 mL; .1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride; Nepafenac | 1 mg/1 mL; .5 mg/1 mL; .1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Nepafenac | 1 mg/1 mL; .1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Sodium Phosphate; Bromfenac | 1 mg/1 mL; .075 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Sodium Phosphate; Bromfenac; Gatifloxacin | 1 mg/1 mL; .75 mg/1 mL; 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Sodium Phosphate; Bromfenac; Gatifloxacin | 1 mg/1 mL; .75 mg/1 mL; 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Sodium Phosphate; Gatifloxacin | 1 mg/1 mL; .5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Tropicamide; Cyclopentolate; Phenylephrine Hydrochloride | 1 mg/1 mL; 1 mg/1 mL; 2.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Tropicamide; Proparacaine Hydrochloride; Phenylephrine Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; 2.5 mg/1 mL; .5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclosporine | .1 g/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Imprimis NJOF, LLC(080431967)" | Epinephrine Hydrochloride; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Hydromorphone Hydrochloride | .5 mg/.5 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Hydromorphone Hydrochloride | .2 mg/.2 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Hydromorphone Hydrochloride | 30 mg/30 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Magnesium Sulfate Heptahydrate | 2 g/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Neostigmine Methylsulfate | 5 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Oxytocin | 30 [USP'U]/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Phenylephrine Hydrochloride | 1 mg/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Potassium Chloride; Lidocaine Hydrochloride | 10 meq/100 mL; 10 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Succinylcholine Chloride | 100 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Cefazolin Sodium | 3 g/123 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | "vasopressin, Unspecified" | 2 U/2 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Ephedrine Sulfate | 25 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Fentanyl Citrate | 1500 ug/30 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | Fentanyl Citrate | 2500 ug/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "KRS GLOBAL BIOTECHNOLOGY, INC.(014763459)" | Cholecalciferol | 50000 [iU]/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "KRS GLOBAL BIOTECHNOLOGY, INC.(014763459)" | Cholecalciferol | 5000 [iU] | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-903 | 69374-903-05 | Glycopyrrolate | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-903 | 69374-903-03 | Glycopyrrolate | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "Nephron Sterile Compounding Center, LLC(079468792)" | 69374-983 | 69374-983-01 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 |